MDL 29913
MDL 29913, a cyclic pseudopeptide, is a competitive NK2 tachykinin receptor selective antagonist, with a pA2 of 8.66[1].
Product Specifications
CAS Number
135721-56-1
UNSPSC
12352209
Target
Neurokinin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/mdl-29913.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H](C(NCC(NC(CN([C@H](C(N[C@H](C(N1)=O)CCC(N)=O)=O)CC(C)C)C)CC(C)C)=O)=O)CC2=CC=CC=C2)[C@@H]1CC3=CNC4=CC=CC=C34
Molecular Formula
C40H56N8O6
Molecular Weight
744.92
References & Citations
[1]C A Maggi, et al. MEN 10,573 and MEN 10,612, novel cyclic pseudopeptides which are potent tachykinin NK-2 receptor antagonists. Regul Pept. 1993 Sep 3;47 (2) :151-8.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH032138-01 10 µg
Recombinant Human Cadherin-16/CDH16 Protein (His Tag)
Sign In for Pricing
View Details PKSH032138-02 50 µg
Recombinant Human Cadherin-16/CDH16 Protein (His Tag)
Sign In for Pricing
View Details 
